GT Biopharma (OXIA.F) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.6
-1.16
-0.73
-0.29

Details

Expected EPS
-0.326914
Actual EPS
-0.7140489999999999
Surprise EPS
-0.39
Surprise Percent
+118.42%

Description

GT Biopharma (OXIA.F) has reported earnings of -0.7140489999999999 per share for Q4 2025.

0 Comments

Share your thoughts